Literature DB >> 1521044

Determinants of a genotoxic effect of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human diploid fibroblasts.

C Pohlmann1, F Koops, J Berg, O Holz, U Ehlert, H W Rüdiger.   

Abstract

The induction of micronuclei was studied in human diploid fibroblasts incubated in the presence of the tobacco-specific nitrosamine NNK. We used four fibroblast strains having a high capacity of O6-alkylguanine DNA alkyltransferase (13.0-23.3 pmol O6-methylguanine repaired per 8 x 10(6) cells) and four strains that showed no detectable repair capacity. Incubation with NNK doubled the frequency of micronuclei in repair-deficient cells but failed to evoke any effect in the proficient cell strains. Control experiments were performed with the direct methylating agent MNNG and in the presence of inhibitors of either metabolic activation or alkyltransferase. The results showed that the genotoxicity of NNK is dependent on the relationship between its metabolic activation and the constitutive DNA repair. This supports earlier findings that low constitutive levels of O6-alkylguanine DNA alkyltransferase may increase susceptibility to lung cancer after exposure to DNA methylating agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521044     DOI: 10.1007/bf00184665

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  13 in total

1.  Mutagenic and cytogenetic studies of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  P R Padma; A J Amonkar; S V Bhide
Journal:  Cancer Lett       Date:  1989-08       Impact factor: 8.679

Review 2.  The relevance of tobacco-specific nitrosamines to human cancer.

Authors:  S S Hecht; D Hoffmann
Journal:  Cancer Surv       Date:  1989

3.  Solutions to the kinetic problem in the micronucleus assay.

Authors:  M Fenech; A Morley
Journal:  Cytobios       Date:  1985

4.  Metabolism of tobacco-specific N-nitrosamines by cultured human tissues.

Authors:  A Castonguay; G D Stoner; H A Schut; S S Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

5.  Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.

Authors:  A Rivenson; D Hoffmann; B Prokopczyk; S Amin; S S Hecht
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

6.  Cytotoxicity, sister-chromatid exchanges and DNA single-strand breaks induced by 4-oxo-4-(3-pyridyl)butanal, a metabolite of a tobacco-specific N-nitrosamine.

Authors:  M A Alaoui-Jamali; R Gagnon; N el Alami; A Castonguay
Journal:  Mutat Res       Date:  1990-01       Impact factor: 2.433

7.  Micronucleus assay in human fibroblasts: a measure of spontaneous chromosomal instability and mutagen hypersensitivity.

Authors:  N L Rudd; D I Hoar; C L Greentree; L S Dimnik; U G Hennig
Journal:  Environ Mol Mutagen       Date:  1988       Impact factor: 3.216

8.  Induction of sister chromatid exchanges by tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human and hamster cells.

Authors:  D Zimonjic; N C Popescu; J A DiPaolo
Journal:  Carcinogenesis       Date:  1989-04       Impact factor: 4.944

9.  Carcinogenicity studies on the two tobacco-specific N-nitrosamines, N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  P R Padma; V S Lalitha; A J Amonkar; S V Bhide
Journal:  Carcinogenesis       Date:  1989-11       Impact factor: 4.944

10.  Correlation between O6-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  J Domoradzki; A E Pegg; M E Dolan; V M Maher; J J McCormick
Journal:  Carcinogenesis       Date:  1984-12       Impact factor: 4.944

View more
  1 in total

1.  Micronuclei in genotoxicity assessment: from genetics to epigenetics and beyond.

Authors:  Lidiya Luzhna; Palak Kathiria; Olga Kovalchuk
Journal:  Front Genet       Date:  2013-07-11       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.